miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy.
Lisa Svartdal NormannMads Haugland HaugenMiriam Ragle AureVessela N KristensenGunhild Mari MælandsmoKristine Kleivi SahlbergPublished in: Breast cancer (Dove Medical Press) (2022)
miR-101-5p acts as a tumor suppressor by inducing apoptosis in HER2+ breast cancer and sensitizes cells with initially poor response to lapatinib and trastuzumab.